Default: Neoplasma

ISSN: 0028-2685

Journal Home

Journal Guideline

Neoplasma Q2 Unclaimed

Vydavatel'stvo Slovenkej Akademie Vied/Veda Publishing House of the Slovak Academy of Sciences Slovakia
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Neoplasma is a journal indexed in SJR in Cancer Research with an H index of 57. It has an SJR impact factor of 0,588 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,588.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Medicine (miscellaneous) (Q2) Cancer Research (Q3) Oncology (Q3)
Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Neoplasma

0,588

SJR Impact factor

57

H Index

67

Total Docs (Last Year)

448

Total Docs (3 years)

51

Total Refs

1037

Total Cites (3 years)

448

Citable Docs (3 years)

2.01

Cites/Doc (2 years)

0.76

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Maspin and Nm23-H1 expression in colorectal cancer

View more

VARIATION OF BONE MARROW CD34+ CELL SUBSETS IN MYELODYSPLASTIC SYNDROMES ACCORDING TO WHO TYPES

View more

Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer

View more

Ovarian cancer: Origin and factors involved in carcinogenesis with potential use in diagnosis, treatment and prognosis of the disease

View more

Evaluation of TNF superfamily molecules release by neutrophils and B leukemic cells of patients with chronic B -cell lymphocytic leukemia

View more

Ex vivo assessment of protective effects of carvacrol against DNA lesions induced in primary rat cells by visible light excited methylene blue (VL+MB)

View more

Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance

View more

Use of direct sequencing for detection of mutations in the BCR-ABL kinase domain in Slovak patients with chronic myeloid leukemia

View more

L-17 family cytokines in neutrophils of patients with oral epithelial squamous cell carcinoma

View more

Diagnosis and surgical therapy of plasma cell neoplasia of the spine

View more

Anal cancer chemoirradiation with curative intent -a single institution experience

View more

Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus

View more
SHOW MORE ARTICLES

Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer

View more

Gemcitabine and carboplatin treatment in Patients with relapsing ovarian cancer

View more

Molecular predictive factors of outcome of radiotherapy in cervical cancer

View more

beta-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways

View more

Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer

View more

Estrogen-dependent Regulation of PPAR- gamma Signaling on Collagen Biosynthesis in Adenocarcinoma Endometrial Cells

View more

Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation

View more

BRCA1/2 status and clinicopathologic characteristics of patients with double primary breast and ovarian cancer

View more

Percutaneous US-guided needle biopsies of solid renal masses

View more

E-Cadherin truncation and Sialyl Lewis-X overexpression in oral squamous cell carcinoma and oral precancerous conditions

View more

Non-nuclear activation of Signal transducer and activator of transcription 3 by 17beta- estradiol in endometrial cancer cells

View more

Depression symptoms and health-related quality of life among patients with metastatic breast cancer in programme of palliative cancer care

View more

FAQS